Skip to main content
. 2017 Jun 9;7(6):840–858. doi: 10.1007/s13346-017-0389-0

Fig. 6.

Fig. 6

Anti-SHIV-RT activity of MZC and MZCL IVRs in macaques following repeated co-challenge with SHIV-RT and HSV-2. (a) The percent of macaques remaining SHIV negative over time was calculated by measuring SIV RNA in plasma collected immediately before each challenge (n = 4 LNG, n = 12 MZCL, n = 4 placebo, n = 12 MZC). (b) Plasma viral loads and (c) antibody development were monitored over time